73.3% of recorded cases were characterized by intensive care treatment, with a median duration of stay of 4 days and a median hospitalization stay of 8 days. 86% of cases experienced severe disease; however, the patients were generally older and suffered from more gastrointestinal and cardiovascular symptoms than a mild course of MIS-C. Laboratory tests done in patients with severe manifestations of MIS-C showed lower WBC counts; increased lymphopenia; higher CRP and ferritin; higher platelet counts, D-dimer and troponin. Of the eighteen deaths reported, 16.7% were patients less than 1 year old, 50% were between the ages of 5-12, and 33.3% were older than 13 years. The majority of patients were male (72.3%) and Black (62.5%). Comorbidities exacerbating fatal cases included obesity, acute leukemia, glucose-6-phosphate dehydrogenase deficiency, asthma and certain neurological conditions.